Metrics as of 10/13/2026, 06:34 PM (Berlin time), refresh in progress.
Vicore Pharma Holding AB Stock
Vicore Pharma Holding AB
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Sweden
- CEO
- Ahmed Mousa
- Employees
- 37
- Market cap
- $2.5 B
- IPO
- 02/07/2026
Vicore Pharma Holding AB is a pharmaceutical company operating in the Healthcare sector, specifically within the Biotechnology industry. Headquartered in Stockholm, Sweden, the company focuses on the development of drugs with an emphasis on interstitial lung diseases and related indications. Its drug development…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Vicore Pharma Holding AB stock: price history
1D
-3.0%
1W
+2.4%
1M
-17.0%
6M
–
YTD
–
1Y
–
2Y
–
5Y
–
10Y
–
Next earnings date
Next earnings date
No date known
Volatility around earnings
~34% stronger price swings than usual
Ask the agents about Vicore Pharma Holding AB
Analyst assessment of Vicore Pharma Holding AB
PRICE TARGET LOW
US$25.00
CONSENSUS
US$25.00
MEDIAN
US$25.00
PRICE TARGET HIGH
US$25.00
No current analyst ratings available.
Vicore Pharma Holding AB stock metrics
P/E
-9.49
P/B
283.87
EV/EBITDA
-100.83
RETURN ON EQUITY
-16.7%
NET MARGIN
-6,454.8%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
70.6%
FLOAT SHARES
198,621,936
AVG. DAILY VOLUME (30D)
29,881
Comparable stocks
Frequently asked questions about Vicore Pharma Holding AB stock
What does Vicore Pharma Holding AB do?
Vicore Pharma Holding AB is a company in the Healthcare sector, Biotechnology industry, headquartered in Sweden.
The CEO is Ahmed Mousa, the company employs around 37 people.
The IPO was on 02/07/2026; the stock trades on NASDAQ under the ticker VCRE.
What do analysts say about Vicore Pharma Holding AB stock?
The average price target is US$25.00, ranging from US$25.00 to US$25.00, with a median of US$25.00.
This is an external assessment, not a statement by Market Jury.
When does Vicore Pharma Holding AB report next?
Around past earnings, price swings were roughly 34% stronger than usual.
Does Vicore Pharma Holding AB pay a dividend?
No, Vicore Pharma Holding AB currently does not pay a dividend.
Which stocks are comparable to Vicore Pharma Holding AB?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, argenx, Revolution Medicines, BeOne Medicines, Incyte and Genmab A/S.
How can I get Vicore Pharma Holding AB stock analyzed?
Clicking "Analyze stock" lets five strategies assess Vicore Pharma Holding AB against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.